Skip to content

Zymeworks Inc.

company

ZYME Nasdaq SEC CIK 1937653

Follow Zymeworks Weekly email: filings, results, news

News

6 stories filed under Zymeworks, grouped into ongoing threads

Biopharma

Thread · 2 stories

Zymeworks Completes Acquisition of Theravance Biopharma

Deals 1 d ago also on TBPH ET

Zymeworks: Transitioning Into A Royalty-Driven Biopharma Platform Post Ziihera Approval

Markets 28 d ago

FDA

Thread · 2 stories

H.C. Wainwright raises Zymeworks stock price target to $55 on FDA approval

Markets 28 d ago 3 sources

Zymeworks Shares Rise Ahead of Key FDA Decision on Zanidatamab

Markets 31 d ago

More coverage

Why is Zymeworks stock surging today?

Markets 31 d ago

Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Deals 49 d ago

Profile

Headquarters: MIDDLETOWN, DE, United States
Founded: 2003
Sector: Healthcare
Industry: Pharmaceutical Preparations
Website: zymeworks.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

News · 6 stories clustered from the RSS aggregator